Streetbeat News

Regulatory

BCRX

BioCryst Pharmaceuticals will present two abstracts featuring data on ORLADEYO (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2023 European Academy of Allergy and Clinical Immunology (EAACI) congress in Hamburg, Germany.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:04 am

IGMS

IGM Biosciences has received FDA clearance to begin Phase 1b clinical studies of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell engager, for severe systemic lupus erythematosus (SLE) and severe rheumatoid arthritis (RA). Patient enrollment is expected to start in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:02 am

QQQ

SPY

US stock futures indicate a weaker open on Wednesday due to uncertainty over the budget bill and non-farm payroll data. Analyst Gina Bolvin sees potential for stock outperformance this year despite volatility. In premarket trading, SPY and QQQ ETFs fell 0.20% and 0.19% respectively.

Portfolio Pulse from Shanthi Rexaline

May 31, 2023 | 10:59 am

SPY

U.S. Republican Representative McHenry stated that the debt ceiling bill should pass on Wednesday, according to CNBC.

Portfolio Pulse from Charles Gross

May 31, 2023 | 10:39 am

BRTX

BioRestorative Therapies has announced that its license will enable expanded clinical operations for investigator-initiated trials and potential 'right to try' uses of BRTX-100.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 10:32 am

BRTX

BioRestorative Therapies (NASDAQ:BRTX) has obtained a license from the New York State Department of Health to act as a tissue bank for processing mesenchymal stem cells from autologous donors. This makes BioRestorative the first facility in New York State to be licensed for this purpose.

Portfolio Pulse from Anusuya Lahiri

May 31, 2023 | 10:31 am

BRTX

BioRestorative Therapies has received a license from the New York State Department of Health to act as a tissue bank for mesenchymal stem cell processing.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 10:30 am

FXI

SPY

TSLA

China's Commerce Ministry announced that the country will continue to support the long-term, stable development of foreign firms operating in China.

Portfolio Pulse from Charles Gross

May 31, 2023 | 9:37 am

FXI

SPY

TSLA

China's Commerce Minister met with Tesla's Elon Musk to discuss China-US economic and trade cooperation, including Tesla's development in China.

Portfolio Pulse from Charles Gross

May 31, 2023 | 9:34 am

CS

FXI

UBS

Credit Suisse has dropped plans to set up a locally incorporated bank in China to avoid potential regulatory issues related to its merger with UBS.

Portfolio Pulse from Charles Gross

May 31, 2023 | 8:57 am